Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.72 USD | -0.51% | -0.31% | -41.02% |
04-29 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
04-26 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.02% | 2.17B | |
+115.18% | 703M | |
+4.72% | 539M | |
-60.63% | 168M | |
-43.88% | 74.58M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- UBS Lowers Teladoc's Price Target to $135 From $142 on Margin Expectations; Neutral Rating Kept